TELA Bio Future Growth
Future criteria checks 2/6
TELA Bio is forecast to grow earnings and revenue by 51.9% and 21.5% per annum respectively while EPS is expected to grow by 52.5% per annum.
Key information
51.9%
Earnings growth rate
52.5%
EPS growth rate
| Medical Equipment earnings growth | 16.1% |
| Revenue growth rate | 21.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 10 Apr 2024 |
Recent future growth updates
Recent updates
Earnings Update: TELA Bio, Inc. (NASDAQ:TELA) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Mar 24
Many Still Looking Away From TELA Bio, Inc. (NASDAQ:TELA)
Mar 08TELA Bio (NASDAQ:TELA) Has Debt But No Earnings; Should You Worry?
Oct 07Getting In Cheap On TELA Bio, Inc. (NASDAQ:TELA) Might Be Difficult
Jul 31TELA Bio: Tailwinds In Hernia Repair Market And Promising Clinical Data To Drive Accelerating Adoption
Oct 02Tela Bio prices $32M common stock offering
Aug 16Is TELA Bio (NASDAQ:TELA) Using Debt Sensibly?
May 12TELA Bio - Follow Up With Management
Jan 14Our First Look At TELA Bio
Nov 04TELA Bio Plugging Away
Oct 25TELA Bio (TELA) Investor Presentation - Slideshow
May 26Bearish: Analysts Just Cut Their TELA Bio, Inc. (NASDAQ:TELA) Revenue and EPS estimates
Mar 30Health Check: How Prudently Does TELA Bio (NASDAQ:TELA) Use Debt?
Feb 12
TELA Bio guides Q4 and FY20 revenue below consensus
Jan 14TELA Bio EPS misses by $0.09, beats on revenue
Nov 11Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 119 | -15 | N/A | N/A | 3 |
| 12/31/2025 | 94 | -35 | N/A | N/A | 5 |
| 12/31/2024 | 75 | -47 | N/A | N/A | 5 |
| 12/31/2023 | 58 | -47 | -41 | -41 | N/A |
| 9/30/2023 | 53 | -44 | -42 | -41 | N/A |
| 6/30/2023 | 49 | -44 | -43 | -41 | N/A |
| 3/31/2023 | 45 | -45 | -44 | -42 | N/A |
| 12/31/2022 | 41 | -44 | -43 | -41 | N/A |
| 9/30/2022 | 38 | -43 | -40 | -39 | N/A |
| 6/30/2022 | 35 | -40 | -39 | -38 | N/A |
| 3/31/2022 | 32 | -36 | -33 | -32 | N/A |
| 12/31/2021 | 29 | -33 | -31 | -30 | N/A |
| 9/30/2021 | 27 | -32 | -28 | -28 | N/A |
| 6/30/2021 | 24 | -32 | -25 | -25 | N/A |
| 3/31/2021 | 20 | -30 | -26 | -26 | N/A |
| 12/31/2020 | 18 | -29 | -25 | -24 | N/A |
| 9/30/2020 | 17 | -28 | -25 | -25 | N/A |
| 6/30/2020 | 16 | -27 | -28 | -26 | N/A |
| 3/31/2020 | 16 | -29 | -27 | -25 | N/A |
| 12/31/2019 | 15 | -30 | -28 | -26 | N/A |
| 9/30/2019 | 13 | -32 | -28 | -24 | N/A |
| 6/30/2019 | 11 | -30 | -24 | -22 | N/A |
| 3/31/2019 | 10 | -28 | -24 | -22 | N/A |
| 12/31/2018 | 8 | -30 | -21 | -20 | N/A |
| 12/31/2017 | 4 | -27 | -16 | -16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TELA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TELA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TELA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TELA's revenue (21.5% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: TELA's revenue (21.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TELA's Return on Equity is forecast to be high in 3 years time